Growth of breast cancer cells by leptin is mediated via activation of the inflammasome: Critical roles of estrogen receptor signaling and reactive oxygen species production - PubMed (original) (raw)

Growth of breast cancer cells by leptin is mediated via activation of the inflammasome: Critical roles of estrogen receptor signaling and reactive oxygen species production

Pawan Kumar Raut et al. Biochem Pharmacol. 2019 Mar.

Abstract

Leptin, a hormone primarily derived from adipose tissue, is known to induce tumor growth, but its underlying mechanisms of action are not clearly understood. Inflammasomes, acting as signaling platforms for controlling inflammatory responses, modulate tumor growth in a complicated manner. In this study, we investigated the role of inflammasomes in leptin-induced growth of breast cancer cells. Herein, we showed that leptin activated NLRP3 inflammasomes in MCF-7 breast cancer cells, as determined by activation of caspase-1, maturation of interleukin-1β, and increased expression of the inflammasome components, including NLRP3 and ASC. Interestingly, inhibition of the inflammasome by treatment with a pharmacological inhibitor of caspase-1 or gene silencing of NLRP3 prevented leptin-induced increase in cell viability. Moreover, suppression of apoptosis and cell cycle promotion by leptin were also significantly abolished by gene silencing of NLRP3, clearly indicating a crucial role of NLRP3 inflammasomes in leptin-induced breast cancer growth. In addition, inhibition of estrogen receptor signaling or ROS production markedly blocked leptin-induced activation of NLRP3 inflammasomes, suggesting that estrogen receptor signaling and ROS production mediate inflammasomes activation by leptin. The stimulatory effect of leptin on inflammasomes activation was also observed in MCF-7 tumor xenograft model. Furthermore, the critical roles of inflammasomes activation in leptin-induced tumor growth, suppression of apoptotic gene expression, and induction of the genes stimulating cell cycle were confirmed in a tumor xenograft model. Taken together, these results demonstrate that inflammasomes activation plays a pivotal role in leptin-induced growth of breast cancer cells via modulation of both apoptosis and cell cycle.

Keywords: Breast cancer; Estrogen receptor; Inflammasomes; Leptin; ROS.

PubMed Disclaimer

Cited by

NLRP3 inflammasome-mediated cytokine production and pyroptosis cell death in breast cancer.
Faria SS, Costantini S, de Lima VCC, de Andrade VP, Rialland M, Cedric R, Budillon A, Magalhães KG. Faria SS, et al. J Biomed Sci. 2021 Apr 12;28(1):26. doi: 10.1186/s12929-021-00724-8. J Biomed Sci. 2021. PMID: 33840390 Free PMC article. Review.
AIM2 upregulation promotes metastatic progression and PD-L1 expression in lung adenocarcinoma.
Zheng JQ, Lin CH, Lee HH, Chang WM, Li LJ, Su CY, Lee KY, Chiu HW, Lin YF. Zheng JQ, et al. Cancer Sci. 2023 Jan;114(1):306-320. doi: 10.1111/cas.15584. Epub 2022 Sep 29. Cancer Sci. 2023. PMID: 36104978 Free PMC article.
Cellular mechanisms linking cancers to obesity.
Liu XZ, Pedersen L, Halberg N. Liu XZ, et al. Cell Stress. 2021 Apr 12;5(5):55-72. doi: 10.15698/cst2021.05.248. Cell Stress. 2021. PMID: 33987528 Free PMC article. Review.
NLRP3 augmented resistance to gemcitabine in triple-negative breast cancer cells via EMT/IL-1β/Wnt/β-catenin signaling pathway.
Zheng Q, Yao D, Cai Y, Zhou T. Zheng Q, et al. Biosci Rep. 2020 Jul 31;40(7):BSR20200730. doi: 10.1042/BSR20200730. Biosci Rep. 2020. PMID: 32578856 Free PMC article.
Interleukin-1β Signaling Contributes to Cell Cycle Arrest and Apoptotic Cell Death by Leptin via Modulation of AKT and p38MAPK in Hepatocytes.
Baral A, Park PH. Baral A, et al. Biomol Ther (Seoul). 2024 Sep 1;32(5):611-626. doi: 10.4062/biomolther.2023.232. Epub 2024 Aug 2. Biomol Ther (Seoul). 2024. PMID: 39091024 Free PMC article.

Growth of breast cancer cells by leptin is mediated via activation of the inflammasome: Critical roles of estrogen receptor signaling and reactive oxygen species production - PubMed (original) (raw)